<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00999492</url>
  </required_header>
  <id_info>
    <org_study_id>TMF-09-001</org_study_id>
    <nct_id>NCT00999492</nct_id>
    <nct_alias>NCT01061892</nct_alias>
  </id_info>
  <brief_title>Selection of Aspheric Diffractive Multifocal Intraocular Lens (IOLS) Based on Corneal Wavefront</brief_title>
  <official_title>Selection of Aspheric Diffractive Multifocal IOLS Based on Corneal Wavefront</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mark Packer, MD, FACS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Drs. Fine, Hoffman and Packer, LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Given the availability of aspheric diffractive IOLs with varying negative spherical&#xD;
      aberration it may be feasible, by selecting the best fit IOL, to minimize aberrations and&#xD;
      thereby maximize visual performance.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of spectacle wear</measure>
    <time_frame>3 months postoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency and degree of visual symptoms</measure>
    <time_frame>3 months postoperatively</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">8</enrollment>
  <condition>Cataracts</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TecnisÂ® Multifocal (TMF)</intervention_name>
    <description>Aspheric, diffractive multifocal intraocular lenses</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Scheduled to undergo bilateral cataract or refractive lens surgery&#xD;
&#xD;
          -  Visual potential of 20/30 or better in each eye after lens removal and IOL&#xD;
             implantation&#xD;
&#xD;
          -  Naturally dilated pupil size (in dim light) &gt; 3.5 mm (with no dilation medications)&#xD;
             for both eyes&#xD;
&#xD;
          -  Preoperative regular corneal astigmatism of 2.5 D or less&#xD;
&#xD;
          -  Clear intraocular media other than cataract&#xD;
&#xD;
          -  Availability, willingness, and sufficient cognitive awareness to comply with&#xD;
             examination procedures&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Ocular disease other than cataract which could potentially limit uncorrected visual&#xD;
             acuity or visual performance.&#xD;
&#xD;
          -  Astigmatism not correctable by limbal relaxing incisions (greater than 2.5 D)&#xD;
&#xD;
          -  Use of systemic or ocular medications that may affect visual outcomes&#xD;
&#xD;
          -  Acute or chronic disease or illness that would increase risk or confound study results&#xD;
             (e.g. diabetes mellitus, immunocompromised, etc.)&#xD;
&#xD;
          -  Uncontrolled systemic or ocular disease&#xD;
&#xD;
          -  History of ocular trauma or prior ocular surgery&#xD;
&#xD;
          -  Amblyopia or strabismus&#xD;
&#xD;
          -  Known pathology that may affect visual acuity; particularly retinal changes that&#xD;
             affect vision (macular degeneration, cystoid macular edema, proliferative diabetic&#xD;
             retinopathy, etc.)&#xD;
&#xD;
          -  Diagnosed degenerative visual disorders (e.g. macular degeneration, or other retinal&#xD;
             disorders) that are predicted to cause future acuity losses to a level of worse than&#xD;
             20/30&#xD;
&#xD;
          -  Subjects who may be expected to require retinal laser treatment or other surgical&#xD;
             intervention&#xD;
&#xD;
          -  Capsule or zonular abnormalities that may affect postoperative centration or tilt of&#xD;
             the lens (e.g. pseudoexfoliation syndrome)&#xD;
&#xD;
          -  Pupil abnormalities (non-reactive, tonic pupils or abnormally shaped pupils)&#xD;
&#xD;
          -  Contact lens usage within 6 months for PMMA lenses, 1 month for gas permeable lenses&#xD;
             or 1 week for extended-wear and daily-wear soft lenses&#xD;
&#xD;
          -  Requiring an intraocular lens power &lt;15.0 or &gt;26.0 diopters&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Drs. Fine, Hoffman and Packer, LLC</name>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <zip>97401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <study_first_submitted>October 19, 2009</study_first_submitted>
  <study_first_submitted_qc>October 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2009</study_first_posted>
  <last_update_submitted>February 26, 2014</last_update_submitted>
  <last_update_submitted_qc>February 26, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Drs. Fine, Hoffman and Packer, LLC</investigator_affiliation>
    <investigator_full_name>Mark Packer, MD, FACS</investigator_full_name>
    <investigator_title>Sponsor-Investigator</investigator_title>
  </responsible_party>
  <keyword>Tecnis Multifocal</keyword>
  <keyword>Patients scheduled for cataract or lens replacement surgery with implantation of multifocal intraocular lenses</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>August 4, 2014</submitted>
    <returned>August 20, 2014</returned>
    <submitted>August 28, 2014</submitted>
    <returned>September 5, 2014</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

